Clinical trial
Assessing Modified Olfactory Training to Prevent Cognitive Decline in MCI High-Risk Individuals: A Randomized Controlled Trial Protocol
NCT06821828 is registered in ClinicalTrials.gov with Peking University Third Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Assessing Modified Olfactory Training to Prevent Cognitive Decline in MCI High-Risk Individuals: A Randomized Controlled Trial Protocol
- Lead sponsor
- Peking University Third Hospital
- Phase
- Not applicable
- Overall status
- Not yet recruiting
- Start date
- March 22, 2025
- Completion date
- May 22, 2027
- Enrollment
- 114 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
elderly people, mild cognitive impairment (mci), olfactory dysfunction, subjective cognitive decline (scd)